Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osenses is an Australian biotechnology company that specializes in the production and distribution of high-quality research reagents for the global life sciences community. The company offers an extensive catalog of antibodies, peptides, and ELISA kits, with a specialized focus on areas such as neuroscience, ion channels, and signal transduction. Beyond its off-the-shelf products, Osenses provides comprehensive custom services including antibody development, peptide synthesis, and recombinant protein expression. Their portfolio supports a wide range of applications in academic research, drug discovery, and diagnostic development. By maintaining rigorous validation standards, the company ensures its tools provide reliable results for complex biological studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osenses.